据称可以降低罹患直肠结肠癌的风险。
法国及美国应用西妥昔单抗治疗直肠结肠癌最多，而芬兰最低。
The use of cetuximab for colorectal cancer was highest in France and the United States and lowest in Finland.
在美国直肠结肠癌是男性和女性的第三大常见癌症，而且是第二大致死癌症。
Colorectal cancer is the third most common type of cancer in men and women and is the second-leading cause of cancer-related deaths in the United States.
应用推荐